Question: is this a 2) strong advice, 1) weak advice 0) no advice?

The MBDA score did not reflect clinical disease activity in patients enrolled in AMPLE and should not be used to guide decision-making in the management of RA, particularly for patients who receive abatacept or adalimumab as the first biologic agent.
user
This is a strong advice
assistant